Passage Bio
Pamela H. is a seasoned clinical operations leader with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Clinical Operations at Passage Bio and as an Independent Clinical Operations Consultant at Clinical Elements Consulting LLC, Pamela H. specializes in the planning and execution of clinical trial programs, particularly in cell and gene therapies. Prior roles include Executive Director of Clinical Operations at Tmunity Therapeutics, where responsibilities included overseeing clinical programs focused on CAR T therapies, and various senior positions at REGENXBIO Inc. and AstraZeneca, contributing to a diverse range of clinical operations and development initiatives. Pamela H. holds a Master’s degree in Quality Assurance/Regulatory Affairs from Temple University and a Bachelor's degree in Biology and Psychology from Ursinus College.
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).